Slide background
test
test
test
REGISTER NOW

April 7–8
2022
Basel, Switzerland

Novel Antimicrobials & AMR Diagnostics

6th AMR Conference

AMR Conference

7–8 April 2022, Basel

Thank you to our sponsors, partners and all participants!

SIGN UP FOR OUR NEWSLETTER

The #AMRconference 2020 was a great success. Almost 450 international AMR experts have participated in 26 live sessions which provided a 360 degree overview of the current AMR industry and resulted in engaging discussions.

We look forward to welcoming you again in summer 2021 – hopefully face-to-face.

Here are some key takeaways from the Closing Session:

Play Video

What you can expect

The AMR Conference is a platform to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to market.

More than 400 participants from 25+ countries

High-level panels and expert sessions > live and on-demand

Scientific poster presentations

A wide variety of topics from financing, development & regulation

Virtual 1:1 partnering meetings

SMEs, academics & governmental agencies benefit from discounted fees

2019 Event Highlights

Event Impressions & Testimonials

More than 330 experts joined the 2-day AMR Conference 2019 in Berlin. They called for rapid capital investments and economic incentives in the fight against antimicrobial resistance (AMR). The AMR Conference is a platform for SMEs, start-ups, big pharma, academia, clinicians, investors, public stakeholders and policy-makers to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.

Latest News

in the AMR and antimicrobial space

New modified antibiotic may prove effective against >200 resistant pathogens

To create a novel molecule that may be effective against resistant Gram-negative bacteria, researchers at University…

New WHO pipeline report on bacterial vaccines issued

Vaccines are powerful tools to prevent infections in the first place that could later on lead…

Biomérieux, Evotec and Boehringer Ingelheim team up in new €40m joint venture

The companies Biomériux, Evotec and Boehringer Ingelheim have joined forces against AMR and announced the launch…

We thank our Sponsors & Partners

Supporting Partners

Media Partners